BELIXOS
Live / Registered — Cancelled — Section 71 (as of 26 Feb 2021)
What this means for you
Registered since 06 Apr 2010. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79070762
- Registration number
- 3771836
- Mark type
- Stylized text
- Filed
- 27 May 2009
- Published for opposition
- 19 Jan 2010
- Registered
- 06 Apr 2010
- Attorney of record
- JENNIFER FRASER
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of dermatological diseases and skin disorders; medicines for human purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; medicines for veterinary purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for medical purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for veterinary purposes, namely, medicines for the treatment of dermatological diseases and skin disorders; topical ointment and gels for the medical and therapeutic treatment of dermatological diseases and skin disorders; [ * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plamacytoma, for the stimulation of the bone marrow function and nutritional or dietary supplements * ] * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of side-effects occurring during the treatment of cancer and leukemia, particularly pharmaceutical preparations on the basis of mistletoes for the treatment of precancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plasmacytoms, for stimulating the bone marrow functions and as nutritional supplements *
Owner
- Biofrontera Pharma GmbH, 51377 Leverkusen, DE
- Biofrontera Pharma GmbH, DE
- Biofrontera Pharma GmbH, DE
Prosecution history
- 15 Jan 2022 — TOTAL INVALIDATION PROCESSED BY THE IB
- 19 Dec 2021 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 18 Dec 2021 — INVALIDATION PROCESSED
- 26 Oct 2021 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 26 Feb 2021 — CANCELLED SECTION 71
- 13 Jun 2019 — INTERNATIONAL REGISTRATION RENEWED
- 06 Apr 2019 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 12 May 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 May 2017 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 08 Sept 2016 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 08 Sept 2016 — INVALIDATION PROCESSED
- 08 Sept 2016 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 08 Jan 2016 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 08 Jan 2016 — REGISTERED-SEC.71 ACCEPTED
- 08 Jan 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL